Q3 2015
Released Nov 12, 2015, after the close
10-Q filed Nov 12, 2015, 43 days after period end · 0001144204-15-064690
Q3 2015 · 10-Q
Revenue—
Net Income-$6.37M-$6.37M N/M vs Q3 2014N/M vs Q2 2015
EPS Diluted-$0.35-$0.35 N/M vs Q3 2014N/M vs Q2 2015
Operating Income-$6,433,988N/M
Operating Cash Flowderived-$5,557,897N/M
Free Cash Flowderived-$5,571,808N/M
What the release said
The release
Same quarter
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 |
| Net Income | -$6.37M | -$4.09M | -$3.48M | -$1.01M |
| EPS Diluted | -$0.35 | -$0.32 | -$0.39 | -$0.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR